Cargando…

Time from first seen in specialist care to surgery does not influence survival outcome in patients with upfront resected pancreatic adenocarcinoma

BACKGROUND: This study evaluated the impact of time to surgery (TTS) on overall survival (OS), disease free survival (DFS) and postoperative complication rate in patients with upfront resected pancreatic adenocarcinoma (PA). METHODS: We retrospectively included patients who underwent upfront surgery...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brugel, M., Bouché, O., Kianmanesh, R., Teuma, L., Tashkandi, A., Regimbeau, J. M., Pessaux, P., Royer, B., Rhaiem, R., Perrenot, C., Neuzillet, C., Piardi, T., Deguelte, S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8649990/ https://www.ncbi.nlm.nih.gov/pubmed/34876080 http://dx.doi.org/10.1186/s12893-021-01409-7

Ejemplares similares

Neoadjuvant chemotherapy for borderline resectable and upfront resectable pancreatic cancer increasing overall survival and disease-free survival?
por: Fossaert, Violette, et al.
Publicado: (2022)

Is there a place for microwave ablation under Pringle maneuver for perivascular colorectal liver metastases?: Reponse to “ Laparoscopic liver resection for liver tumors in proximity to major vasculature: A single-center comparative study”
por: Rhaiem, Rami, et al.
Publicado: (2020)

Implications of RAS Mutations on Oncological Outcomes of Surgical Resection and Thermal Ablation Techniques in the Treatment of Colorectal Liver Metastases
por: Rhaiem, Rami, et al.
Publicado: (2022)

Sequential treatment of rupture of pseudoaneurysm of hepatic artery with peritoneal patch and radiological embolization
por: Tashkandi, A, et al.
Publicado: (2019)

High amylase concentration in drainage liquid can early predict proximal and distal intestinal anastomotic leakages: A prospective observational study
por: Amroun, Koceila, et al.
Publicado: (2023)

Microwave Ablation for Colorectal Liver Metastases: A Systematic Review and Pooled Oncological Analyses
por: Mimmo, Antonio, et al.
Publicado: (2022)

Asymptomatic stenosis of a celiacomesenteric trunk
por: Hammoutene, Cheryne, et al.
Publicado: (2022)

Laparoscopic hybrid pancreaticoduodenectomy: Initial single center experience
por: Al-Sadairi, Abdul Rahman, et al.
Publicado: (2021)

Preoperative magnetic resonance cholangiopancreatography before planned laparoscopic cholecystectomy: is it necessary?
por: Rhaiem, Rami, et al.
Publicado: (2019)

Surgery and Perioperative Management in Small Intestinal Neuroendocrine Tumors
por: Deguelte, Sophie, et al.
Publicado: (2020)

Meta‐analysis comparing upfront surgery with neoadjuvant treatment in patients with resectable or borderline resectable pancreatic cancer
por: Versteijne, E., et al.
Publicado: (2018)

Prediction of Early Distant Recurrence in Upfront Resectable Pancreatic Adenocarcinoma: A Multidisciplinary, Machine Learning-Based Approach
por: Palumbo, Diego, et al.
Publicado: (2021)

Recurrence Patterns for Pancreatic Ductal Adenocarcinoma after Upfront Resection Versus Resection Following Neoadjuvant Therapy: A Comprehensive Meta-Analysis
por: Ratnayake, Bathiya, et al.
Publicado: (2020)

Reperfused human cadaver as a new simulation model for colonoscopy: a pilot study
por: Rohr, A., et al.
Publicado: (2022)

Short-term and middle-term evaluation of laparoscopic hepatectomies compared with open hepatectomies: A propensity score matching analysis
por: Untereiner, Xavier, et al.
Publicado: (2016)

Assessing abdominal aortic calcifications before performing colocolic or colorectal anastomoses: A case–control study
por: Deguelte, Sophie, et al.
Publicado: (2021)

Early Recurrence after Upfront Surgery for Pancreatic Ductal Adenocarcinoma
por: Nappo, Gennaro, et al.
Publicado: (2023)

Network meta-analysis comparing neoadjuvant chemoradiation, neoadjuvant chemotherapy and upfront surgery in patients with resectable, borderline resectable, and locally advanced pancreatic ductal adenocarcinoma
por: Hu, Qiancheng, et al.
Publicado: (2019)

Optimal approach for upfront resectable non-small-cell lung cancer
por: van Meerbeeck, Jan P.
Publicado: (2013)

Family Doctors Seen through the Eyes of Specialists: A Qualitative Study
por: Probst, Anna, et al.
Publicado: (2013)

Post-hepatectomy liver failure: Should we consider venous outflow?
por: Lhuaire, Martin, et al.
Publicado: (2015)

Neoadjuvant chemotherapy with or without radiotherapy versus upfront surgery for resectable pancreatic adenocarcinoma: a meta-analysis of randomized clinical trials
por: Ghanem, I., et al.
Publicado: (2022)

Impact of the COVID-19 pandemic on disease stage and treatment for patients with pancreatic adenocarcinoma: A French comprehensive multicentre ambispective observational cohort study (CAPANCOVID)
por: Brugel, Mathias, et al.
Publicado: (2022)

Efficacy of upfront hepatectomy without neoadjuvant chemotherapy for resectable colorectal liver metastasis
por: Ono, Kosuke, et al.
Publicado: (2021)

Prognostic Impact of Tumor-Infiltrating Lymphocytes and Neutrophils on Survival of Patients with Upfront Resection of Pancreatic Cancer
por: Miksch, Rainer C., et al.
Publicado: (2019)

Impact of radiologic splenic vessel invasion in resectable left-sided pancreatic ductal adenocarcinoma: predictor of early systemic recurrence following upfront surgery
por: Lee, Seung Jae, et al.
Publicado: (2022)

Dynamic Prediction of Resectability for Patients with Advanced Ovarian Cancer Undergoing Neo-Adjuvant Chemotherapy: Application of Joint Model for Longitudinal CA-125 Levels
por: Amroun, Koceila, et al.
Publicado: (2022)

Clinical Outcomes of Upfront Primary Tumor Resection in Synchronous Unresectable Metastatic Colorectal Cancer
por: Shin, Ji Eun, et al.
Publicado: (2023)

Prolonged Survival in a Patient with Neuroendocrine Tumor of the Cecum and Diffuse Peritoneal Carcinomatosis
por: de Mestier, Louis, et al.
Publicado: (2012)

A predictive model for recurrence after upfront surgery in patients with resectable pancreatic ductal adenocarcinoma (PDAC) by using preoperative clinical data and CT characteristics
por: Tian, Ningzi, et al.
Publicado: (2022)

Upfront whole brain radiotherapy for multiple brain metastases in patients with EGFR-mutant lung adenocarcinoma
por: Li, Changhui, et al.
Publicado: (2019)

Survival outcomes of neoadjuvant therapy followed by radical resection versus upfront surgery for stage I–III pancreatic ductal adenocarcinoma: a retrospective cohort study
por: Zou, Yiping, et al.
Publicado: (2023)

Beta-blocker exposure and survival outcomes in patients with advanced pancreatic ductal adenocarcinoma: a retrospective cohort study (BETAPANC)
por: Le Bozec, Antoine, et al.
Publicado: (2023)

To Be Seen or Not to Be Seen: Latent Infection by Tobamoviruses
por: Ilyas, Rabia, et al.
Publicado: (2022)

Comparison of neoadjuvant therapy and upfront surgery in resectable pancreatic cancer: a meta-analysis and systematic review
por: Ren, Xiaohan, et al.
Publicado: (2019)

Neoadjuvant therapy versus upfront surgery for potentially resectable pancreatic cancer: A Markov decision analysis
por: Bradley, Alison, et al.
Publicado: (2019)

Long‐term survival benefit of upfront chemotherapy in patients with newly diagnosed borderline resectable pancreatic cancer
por: Shrestha, Bikram, et al.
Publicado: (2017)

Survival Benefit after Shifting from Upfront Surgery to Neoadjuvant Treatment in Borderline Resectable Pancreatic Cancer
por: Jeon, Hyun Jeong, et al.
Publicado: (2023)

The experience of neoadjuvant chemotherapy versus upfront surgery in resectable pancreatic cancer: a cross sectional study
por: Su, Yung-Yeh, et al.
Publicado: (2023)

DEBATE UPFRONT vs DELAYED TRANSPLANT
por: Gay, F.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_po8v677efro24q9s1q4347bqej